1993
DOI: 10.1037/0735-7044.107.2.271
|View full text |Cite
|
Sign up to set email alerts
|

Disruption of human eyeblink conditioning after central cholinergic blockade with scopolamine.

Abstract: Human (Homo sapiens) volunteers (N = 72) received saline, a low dose of oral scopolamine (0.6 mg), a high dose of oral scopolamine (1.2 mg), or a peripheral analogue (glycopyrrolate). They then underwent classical conditioning of the eyeblink response to a tone conditioned stimulus (CS) and a corneal airpuff unconditioned stimulus (UCS) in a delay conditioning paradigm. There was a dose-related decline in acquisition of the conditioned response. These drug-induced conditioning deficits were similar to those pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
38
0

Year Published

1996
1996
2013
2013

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 73 publications
(41 citation statements)
references
References 40 publications
3
38
0
Order By: Relevance
“…Sub-seizure electrical stimulation of the hippocampus during delay eyeblink conditioning disrupts the acquisition, but not the expression of eyeblink CRs (Salafia et al 1979). Systemic injection of the cholinergic antagonist scopolamine, which alters hippocampal neuronal activity, severely disrupts delay eyeblink conditioning in rabbits (Moore et al 1976) and in humans (Solomon et al 1993). Lesions of medial septum, which modulates hippocampal activity through cholinergic projections, disrupt the acquisition delay eyeblink conditioning in rabbits (Allen et al 2002).…”
Section: Discussionmentioning
confidence: 99%
“…Sub-seizure electrical stimulation of the hippocampus during delay eyeblink conditioning disrupts the acquisition, but not the expression of eyeblink CRs (Salafia et al 1979). Systemic injection of the cholinergic antagonist scopolamine, which alters hippocampal neuronal activity, severely disrupts delay eyeblink conditioning in rabbits (Moore et al 1976) and in humans (Solomon et al 1993). Lesions of medial septum, which modulates hippocampal activity through cholinergic projections, disrupt the acquisition delay eyeblink conditioning in rabbits (Allen et al 2002).…”
Section: Discussionmentioning
confidence: 99%
“…Drug effects on acquisition are legion. In general, drugs that enhance acetylcholine (ACh) function enhance acquisition, and drugs that impair ACh function impair acquisition, either via actions on nicotinic or muscarinic receptor systems or via acetylcholinesterase (e.g., Solomon et al 1993;Woodruff-Pak and Ewers 2000;see above). Drugs that impair functions of certain types of calcium channels, for example, nimodipine, enhance acquisition and retention of eyeblink conditioning (Deyo et al 1989;Straube et al 1990;Solomon et al 1995;Woodruff-Pak et al 1997), consistent with the putative AHP mechanism operative in hippocampal pyramidal neurons (see above).…”
Section: Modulatory Effects On Eyeblink Conditioningmentioning
confidence: 99%
“…Previous animal studies have demonstrated a retardation in classical conditioning of the eye-Bahro/Molchan/Sunderland/Herscovitch/ Schreurs blink response, a relatively simple form of learning and memory, after scopolamine administration [4][5][6]. Several human eyeblink conditioning studies have also shown that scopolamine produces a retardation in classical eyeblink conditioning [7,8]. The major influence of scopolamine in the central nervous system is on the cholinergic pathways to the hippocampus and neocortex.…”
Section: Introductionmentioning
confidence: 99%